Meenakshi (I) Q1 FY27 Earnings Call — Analysis (BSE: 544831)
Meenakshi India posts core garment operating profit recovery in Q1 FY27, targets 17% EBITDA margin by FY28 and doubles capacity to 38 lakh pieces by FY30
Result quality: poor — Revenue declined. Management sentiment: neutral.
The take
Q1FY27 Revenue from operations ₹32.24 Cr ( −3.4% YoY ) . New guidance — FY28 ebitda margin 17% .
Results
Revenue ₹32.24 Cr (-3.4% YoY); PAT ₹7.12 Cr (+153% YoY) boosted by other income; core garment operating profit turned positive at ₹3.43 Cr vs ₹0.28 Cr YoY
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue from operations | ₹32.24 Cr | −3.4% | yoy · Q1FY27 |
| Profit After Tax (PAT) | ₹7.12 Cr | +153% | yoy · Q1FY27 |
| Core Garment Operating Profit (Textile segment) | ₹3.43 Cr | yoy · Q1FY27 · ₹0.28 Cr in Q1FY26 | |
| Other Income | ₹7.11 Cr | yoy · Q1FY27 · ₹4.03 Cr in Q1FY26 | |
| Total Expenses | ₹31.72 Cr | −6.9% | yoy · Q1FY27 |
| Cost of Materials (% of revenue) | 45.7% | yoy · Q1FY27 · ~48% in Q1FY26 | |
| Employee Benefit Expense | ₹8.94 Cr | yoy · Q1FY27 | |
| Finance Cost | ₹0.10 Cr | none · Q1FY27 | |
| Net Worth | ₹142.65 Cr | sequential · Q1FY27 · Mar-26: ₹150.65 Cr | |
| Cash & Investments | ₹80 Cr | point_in_time · As of Mar-26 | |
| Earnings Per Share (EPS) | ₹6.34 | yoy · Q1FY27 · ₹2.51 in Q1FY26 |
Guidance
Management targets ~17% EBITDA margin by FY28, close to 70% capacity utilisation in FY27, and phased capacity addition to 38 lakh pieces by FY30 with conservative FY30 revenue target of ₹500 Cr
What management committed to
- We are targeting to hit a margin of about 17% by FY28. — 17%, FY28
- Conservative target for FY30: revenue ₹500 Cr and PAT ₹65 Cr. — ₹500 Cr revenue, ₹65 Cr PAT, FY30
- Our expectation is to be utilizing close to 70% capacity in FY2027. — close to 70%, FY27
- First new manufacturing unit operational by FY28 (may be off by a couple of months) at a cost of ~₹20 Cr. — ₹20 Cr, FY28
- Second manufacturing unit expected by FY30 at a similar cost of ~₹20 Cr.
Key themes
Premiumisation, tariff resilience, and capacity expansion
Operational commentary
- Core garment business returned to operating profit (₹3.43 Cr) following corrective measures, reversing prior-year loss.
- All US customers retained despite tariffs; volumes partially reduced but client relationships intact, revenue mix now ~60% Europe / 40% US.
- Phased capacity expansion from 18 lakh pieces to 38 lakh pieces planned: first new factory targeted FY28 (₹20 Cr), second by FY30 (₹20 Cr), total ~₹40-50 Cr.
- MOU signed with Sri Lankan contract manufacturer to offer alternative country-of-origin for US customers under adverse tariff scenarios.
- Evaluating own manufacturing facility outside India (Nepal, Vietnam) to diversify geopolitical risk.
- Developing adjacent product capabilities in women's wear and athleisure to broaden product basket for existing premium clients.
- D2C brand 'SHORTSTOP' test marketing paused due to patent issues; no material investment.
- Balance sheet remains debt-free with ~₹80 Cr cash and investments, supporting organic capex.
Analyst Q&A
Q. What is the margin trajectory back to pre-tariff levels?
We are targeting 17% EBITDA margin by FY28.
Q. What is the capex plan for the incremental 20 lakh pieces capacity and timelines?
First factory by FY28 costing ₹20 Cr, second by FY30, total around ₹40-50 Cr; these are ballpark figures.
Q. Why sign an MOU for contract manufacturing in Sri Lanka if India demand is strong?
To give US customers an alternative country-of-origin in case of adverse tariff changes; the facility will be used only if needed.
Q. Isn't the FY30 guidance of ₹500 Cr revenue and ₹65 Cr PAT conservative given previous EBITDA?
Yes, it is conservative factoring in FTA uncertainty; we are hopeful of surpassing these figures.
Research and educational content only. Not investment advice.